At a glance
- Originator Pharmacia Corporation
- Class Antipsychotics
- Mechanism of Action Dopamine D4 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Schizophrenia
Most Recent Events
- 10 Feb 1999 Discontinued-Preclinical for Schizophrenia in USA (Unknown route)
- 02 May 1997 New profile
- 02 May 1997 Preclinical development for Schizophrenia in USA (Unknown route)